000			01875 a2200445 4500
005			20250516034028.0
264		0	_c20120918
008			201209s 0 0 eng d
022			_a1559-131X
024	7		_a10.1007/s12032-011-9920-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aStępnik, M
245	0	0	_aAssessment of the involvement of oxidative stress and Mitogen-Activated Protein Kinase signaling pathways in the cytotoxic effects of arsenic trioxide and its combination with sulindac or its metabolites: sulindac sulfide and sulindac sulfone on human leukemic cell lines. _h[electronic resource]
260			_bMedical oncology (Northwood, London, England) _cJun 2012
300			_a1161-72 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aArsenic Trioxide
650	0	4	_aArsenicals _xadministration & dosage
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aDrug Synergism
650	0	4	_aGlutathione _xmetabolism
650	0	4	_aHumans
650	0	4	_aLeukemia _xdrug therapy
650	0	4	_aMitogen-Activated Protein Kinases _xmetabolism
650	0	4	_aOxidative Stress _xdrug effects
650	0	4	_aOxides _xadministration & dosage
650	0	4	_aReactive Oxygen Species _xmetabolism
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSulindac _xadministration & dosage
700	1		_aFerlińska, M
700	1		_aSmok-Pieniążek, A
700	1		_aGradecka-Meesters, D
700	1		_aArkusz, J
700	1		_aStańczyk, M
773	0		_tMedical oncology (Northwood, London, England) _gvol. 29 _gno. 2 _gp. 1161-72
856	4	0	_uhttps://doi.org/10.1007/s12032-011-9920-1 _zAvailable from publisher's website
999			_c20788278 _d20788278